Allergan to acquire Repros

By Jennie Walters | Dec 15, 2017 | 6:47 PM GMT

Allergan plc (NYSE:AGN) is acquiring Repros Therapeutics Inc. (NASDAQ:RPRX) for $0.67 per share in cash. Repros said it expects

Read the full 196 word article

How to gain access

Continue reading with a
two-week free trial.